Seminars in Hematology
Volume 43, Supplement 4 , Pages S1-S2, April 2006

Inhibitor Development in Patients With Hemophilia: An Overview

  • Cindy A. Leissinger (Guest Editor)

      Affiliations

    • Corresponding Author InformationAddress correspondence to Cindy A. Leissinger, MD, Section of Hematology/Oncology, Box SL-78, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112.

Tulane University, New Orleans, LA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(06)00048-5

doi:10.1053/j.seminhematol.2006.03.002

Seminars in Hematology
Volume 43, Supplement 4 , Pages S1-S2, April 2006